The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea: Sleep apnea and inflammation

Journal of Sleep Research

Volumn 19, Issue 2, 2010, Pages 341-348

  Sahlman, Johanna ^a   Miettinen, Kati ^a   Peuhkurinen, Keijo ^a   Seppä, Juha ^a   Peltonen, Markku ^b   Herder, Christian ^c   Punnonen, Kari ^d   Vanninen, Esko ^a   Gylling, Helena ^a   Partinen, Markku ^e,f   Uusitupa, Matti ^a   Tuomilehto, Henri ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d OK Kuopio   (Finland)

^e Rinnekoti Foundation Finland   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

Author keywords

C reactive protein; Cytokines; Inflammation; Obstructive; Sleep apnoea

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; IL1RN PROTEIN, HUMAN; INTERLEUKIN 6; OXYGEN;

ADULT; AGED; APNEA HYPOPNEA INDEX; ARTICLE; BODY FAT; BODY MASS; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLEEP APNEA SYNDROME; BLOOD; BLOOD PRESSURE; COMPLICATION; CROSS-SECTIONAL STUDY; IMMUNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SLEEP DISORDERED BREATHING;

BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; OBESITY; OXYGEN; SLEEP APNEA, OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952618489     PISSN: 09621105     EISSN: 13652869     Source Type: Journal    
DOI: 10.1111/j.1365-2869.2009.00787.x     Document Type: Article

References (52)

1. Alberti, A., Sarchielli, P., Gallinella, E. et al. Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study. J. Sleep Res., 2003, 12 : 305 311.
2. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep, 1999, 22 : 667 689.
3. Anguera, I., Miranda-Guardiola, F., Bosch, X. et al. Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina. Am. Heart J., 2002, 144 : 811 817.
4. Arend, W. P., Malyak, M., Guthridge, C. J. Gabay, C. Interleukin-1 receptor antagonist: role in biology. Annu. Rev. Immunol., 1998, 16 : 27 55.
5. Berg, A. H. Scherer, P. E. Adipose tissue, inflammation, and cardiovascular disease. Circ. Res., 2005, 96 : 939 949.
6. Can, M., Acikgoz, S., Mungan, G. et al. Serum cardiovascular risk factors in obstructive sleep apnea. Chest, 2006, 129 : 233 237.
7. Carlson, J. T., Hedner, J. A., Sellgren, J., Elam, M. Wallin, B. G. Depressed baroreflex sensitivity in patients with obstructive sleep apnea. Am. J. Respir. Crit. Care Med., 1996, 154 : 1490 1496.
8. Ciftci, T. U., Kokturk, O., Bukan, N. Bilgihan, A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine, 2004, 28 : 87 91.
9. Collop, N. A., McDowell Anderson, W., Boehlecke, B. et al. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. J. Clin. Sleep Med., 2007, 3 : 737 747.
10. Dyugovskaya, L., Lavie, P. Lavie, L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann. N. Y. Acad. Sci., 2005, 1051 : 340 350.
11. Fietze, I., Dingli, K., Diefenbach, K. et al. Night-to-night variation of the oxygen desaturation index in sleep apnoea syndrome. Eur. Respir. J., 2004, 24 : 987 993.
12. Guilleminault, C., Kirisoglu, C. Ohayon, M. M. C-reactive protein and sleep-disordered breathing. Sleep, 2004, 27 : 1507 1511.
13. Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med., 2005, 352 : 1685 1695.
14. Hartmann, G., Tschop, M., Fischer, R. et al. High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine, 2000, 12 : 246 252.
15. Hayashi, M., Fujimoto, K., Urushibata, K., Takamizawa, A., Kinoshita, O. Kubo, K. Hypoxia-sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome. Respirology, 2006, 11 : 24 31.
16. Hedner, J., Ejnell, H., Sellgren, J., Hedner, T. Wallin, G. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J. Hypertens. Suppl., 1988, 6 : 529 531.
17. Heeschen, C., Dimmeler, S., Hamm, C. W. et al. Serum level of the anti-inflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation, 2003, 107 : 2109 2114.
18. Herder, C., Brunner, E. J., Rathmann, W. et al. Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II Study. Diabetes Care, 2009, 32 : 421 423.
19. Ip, M. S., Tse, H. F., Lam, B., Tsang, K. W. Lam, W. K. Endothelial function in obstructive sleep apnea and response to treatment. Am. J. Respir. Crit. Care Med., 2004, 169 : 348 353.
20. Kasasbeh, E., Chi, D. S. Krishnaswamy, G. Inflammatory aspects of sleep apnea and their cardiovascular consequences. South. Med. J., 2006, 99 : 58 67.
21. Kokturk, O., Ciftci, T. U., Mollarecep, E. Ciftci, B. Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int. Heart J., 2005, 46 : 801 809.
22. Kushida, C. A., Efron, B. Guilleminault, C. A predictive morphometric model for obstructive sleep apnea syndrome. Int. J. Obes. Relat. Metab. Disord., 1993, 17 : 533 540.
23. Larsen, C. M., Faulenbach, M., Vaag, A. et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med., 2007, 356 : 1517 1526.
24. Lavie, L. Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med. Rev., 2003, 7 : 35 51.
25. Liu, H., Liu, J., Xiong, S., Shen, G., Zhang, Z. Xu, Y. The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome. J. Tongji Med. Univ., 2000, 20 : 200 202.
26. Mann, D. L. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ. Res., 2002, 91 : 988 998.
27. van Minkelen, R., Wettinger, S. B., de Visser, M. C. et al., Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction. Atherosclerosis, 2009, 203 : 201 205.
28. Nieto, F. J., Young, T. B., Lind, B. K. et al. Association of sleep-disordered breathing, sleep apnoea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA, 2000, 283 : 1829 1836.
29. Pai, J. K., Pischon, T., Ma, J. et al. Inflammatory markers and the risk of coronary heart disease in men and women. N. Engl. J. Med., 2004, 351 : 2599 2610. (Pubitemid 39628581)
30. Partinen, M. Hublin, C. Epidemiology of sleep disorders. In : M. Kryger W. Dement (Eds) Principles and Practice of Sleep Medicine, 4th edn. Elsevier
31. Peppard, P. E., Young, T., Palta, M. Skatrud, J. Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med., 2000, 342 : 1378 1384. (Pubitemid 30262394)
32. Pillar, G. Shehadeh, N. Abdominal far and sleep apnea: the chicken or the egg. Diabetes Care, 2008, 31 (Suppl. 2 303 309.
33. Punjabi, N. M. Beamer, B. A. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep, 2007, 30 : 29 34.
34. Ridker, P. M., Rifai, N., Pfeffer, M., Sacks, F., Lepage, S. Braunwald, E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation, 2000a, 101 : 2149 2153.
35. Ridker, P. M., Rifai, N., Stampfer, M. J. Hennekens, C. H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation, 2000b, 101 : 1767 1772.
36. Ryan, S., Taylor, C. T. McNicholas, W. T. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am. J. Respir. Crit. Care Med., 2006, 174 : 824 830.
37. Ryan, S., Nolan, G. M., Hannigan, E., Cunningham, S., Taylor, C. McNicholas, W. T. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax, 2007, 62 : 509 514.
38. Saletu, M., Nosiska, D., Kapfhammer, G. et al. Structural and serum surrogate markers of cerebrovascular disease in obstructive sleep apnea (OSA): association of mild OSA with early atherosclerosis. J. Neurol., 2006, 253 : 746 752.
39. Salmi, J. A. Body composition assessment with segmental multifrequency bioimpedance method. J. Sports Sci. Med., 2003, 2 (Suppl. 3 1 29.
40. Shahar, E., Whitney, C. W., Redline, S. et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am. J. Respir. Crit. Care Med., 2001, 163 : 19 25. (Pubitemid 32095247)
41. Shamsuzzaman, A. S., Gersh, B. J. Somers, V. K. Obstructive sleep apnoea. Implications for cardiac and vascular disease. JAMA, 2003, 290 : 1906 1913.
42. Sharma, S. K., Mishra, H. K., Sharma, H. et al. Obesity, and not obstructive sleep apnea, is responsible for increased hs-CRP levels in patients with sleep-disordered breathing in Delhi. Sleep Med., 2008, 9 : 149 156.
43. Stradling, J. Obstructive sleep apnoea. BMJ, 2007, 335 : 313 314.
44. Tedgui, A. Mallat, Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev., 2006, 86 : 515 581.
45. Tocci, M. J. Schmidt, J. A. Interleukin-1: structure and function. In : D. G. Remick J. S. Friedland (Eds) Cytokines in Health and Disease, 2nd edn. Marcel Dekker
46. Tuomilehto, H., Peltonen, M., Partinen, M. et al. Sleep-disordered breathing is related to an increased risk for type 2 diabetes in middle-aged men, but not in women - the FIN-D2D survey. Diabetes Obes. Metab., 2008, 10 : 468 475. (Pubitemid 351639089)
47. Vgontzas, A. N., Papanicolaou, D. A., Bixler, E. O., Kales, A., Tyson, K. Chrousos, G. P. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J. Clin. Endocrinol. Metab., 1997, 82 : 1313 1316. (Pubitemid 27200394)
48. de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G. de Vries, J. E. Interleukin 10 (IL10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med., 1991, 174 : 1209 1220.
49. Wolk, R., Shamsuzzaman, A. S. Somers, V. Obesity, sleep apnea, and hypertension. Hypertension, 2003, 42 : 1067 1074.
50. Yokoe, T., Minoguchi, K., Matsuo, H. et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by continuous positive airway pressure. Circulation, 2003, 107 : 1129 1134.
51. Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S. Badr, S. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med., 1993, 328 : 1230 1235.
52. Young, T., Peppard, P. E. Gottlieb, D. J. Epidemiology of obstructive sleep apnea: a population health perspective. Am. J. Respir. Crit. Care Med., 2002, 165 : 1217 1239.